Photon energy spectrum emitted by a novel polymer-encapsulated 103Pd source and its effect on the dose rate constant.
Photon energy spectrum emitted by a novel polymer-encapsulated 103Pd source and its effect on the dose rate constant.
复制标题
新型聚合物封装 103Pd 源发射的光子能谱及其对剂量率常数的影响。
DOI:
10.1118/1.2870231
复制
发表时间:
2008
期刊:
影响因子:
3.8
通讯作者:
Nath,Ravinder
中科院分区:
文献类型:
--
作者:
Khan,Sabrina;Chen,ZheJay;Nath,Ravinder
Two independent groups have published intrinsic dosimetry parameters for the recently introduced interstitial brachytherapy source which contains encapsulated by a novel polymer shell. The dose rate constant reported by the two groups, however, differed by more than and there is currently no AAPM recommended consensus value for this source in clinical dosimetry. The aim of this work was to perform an independent determination of for the source using a recently developed photon spectrometry technique. Three sources (model 1032P) with known air‐kerma strength were used in this study. The photon energy spectrum emitted along the radial direction on the source's bisector was measured in air using a high‐resolution intrinsic germanium spectrometer designed and established for low‐energy brachytherapy source spectrometry. The dose rate constant of each source was determined from its emitted energy spectrum and the spatial distribution of radioactivity in the source. Unlike other sources made with traditional titanium encapsulation, the photons emitted by the sources exhibited only slight spectral hardening, yielding a relative energy spectrum closer to that emitted by bare . The dose rate constant determined by the photon spectrometry technique for water was . This value agreed, within experimental uncertainties, with the Monte Carlo‐calculated value of and the TLD‐measured value (with a Monte Carlo‐calculated solid‐phantom‐to‐water conversion factor) of reported by Wang and Hertel [Appl. Radiat. Isot. 63, 311–321 (2005)]. However, it differed by from the of reported by Bernard and Vynckier [Phys. Med. Biol. 50, 1493–1504 (2005)]. The results obtained in this work provide additional information needed for establishing a consensus value for the dose rate constant for the source. It suggests that an eventual consensus value of for the source is likely to be closer to a value of rather than as initially recommended by the source manufacturer based on the two previously published results.